Search results
Found 7360 matches for
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
EPSRC Centre for Doctoral Training in Healthcare Data Science
The EPSRC Centre for Doctoral Training in Healthcare Data Science (HDS CDT) is a four-year doctoral training programme offering integrated training and opportunities for study in computational statistics, machine learning, data engineering and infectious disease analytics within the context of ethically-responsible health research. Based at the Oxford Big Data Institute, the HDS CDT will recruit five cohorts from 2024 – 2028.
Inflammatory and Musculoskeletal Disease
The Kennedy Trust for Rheumatology Research-funded OxKen programme will fully fund 4 medical students each year from 2021-5 to undertake DPhils in the Medical Sciences Division in the fields of musculoskeletal disease, inflammation and immunology.
Computational Discovery
The DPhil in Computational Discovery is a multidisciplinary programme spanning projects in Advanced Molecular Simulations, Machine Learning and Quantum Computing to develop new tools and methodologies for life sciences discovery.
DPhil in Cancer Science
The DPhil in Cancer Science programme is unique and distinctive in offering integrated training across the following themes: Immunity, Infection & Inflammation; DNA Damage Response & Radiation Biology; Cancer Genetics & Epigenetics; and Cancer Big Data. It builds on Oxford’s outstanding research record in these areas, spanning both the University and Hospital Trust.